Release of Mast Cell Tryptase from Human Colorectal Mucosa in Inflammatory Bowel Disease

References

• McDermott RP. Aetiology and pathogenesis of inflammatory bowel disease. Curr Opin Gastroenterol 1997;13:302–6.
   Google Scholar
• Schattenfroh S, Bartels M, Nagel E. Early morphologic changes in Crohn’s disease. Acta Anat 1994;149:237–46.
   PubMedGoogle Scholar
• Stenton GR, Vliagoftis H, Befus D. Role of intestinal mast cells in modulating gastrointestinal pathopyhsiology. Ann Allergy Asthma Immunol 1998;81:1–15.
   PubMed Web of Science ®Google Scholar
• Enander I, Matsson P, Nystrand J, Andersson AS, Eklund E, Bradford TR, et al. A new radioimmunoassay for human mast cell tryptase using monoclonal antibodies. J Immunol Methods 1991;138:39–46.
   PubMed Web of Science ®Google Scholar
• Raithel M, Matek M, Baenkler HW, Jorde W, Hahn EG. Mucosal histamine content and histamine secretion in Crohn’s disease, ulcerative colitis and allergic enteropathy. Int Arch Allergy Immunol 1995;108:127–33.
   PubMed Web of Science ®Google Scholar
• Raithel M, Hochberger J, Hahn EG. Effect of colonoscopy- premedication containing diazepam and pethidine on the release of mast cell mediators from gut mucosal samples. Endoscopy 1995;27:415–23.
   PubMedGoogle Scholar
• Raithel M, Schneider Th, Hahn EG. Effect of substance P on histamine secretion from gut mucosa in inflammatory bowel disease. Scand J Gastroenterol 1999;34:496–503.
   PubMed Web of Science ®Google Scholar
• Raithel M, Pacurar A, Winterkamp S, Dalbay S, Ell C, Hahn EG. Analysis and characteristics of mast cell tryptase and eosinophilic cationic protein from human gut mucosa in gastrointestinal allergy. In: Wüthrich B, Ortolani C, editors. Highlights in food allergy. Monographs in allergy. Vol 32. Basel: Karger; 1996. p. 143–56.
   Google Scholar
• Elson CO, Kagnoff MF, Fiocchi C, Befus AD, Targan St. Intestinal immunity and inflammation: recent progress. Gastroenterology 1986;91:746–86.
   Google Scholar
• Dvorak AM, Monahan RA, Osage BE, Dickerson RG. Crohn’s disease: transmission electron microscopic studies: 2: immunologic inflammatory response: alterations of mast cells, basophils, eosinophils, and the microvasculature. Hum Pathol 1980;11: 606–19.
   PubMedGoogle Scholar
• Dvorak AM, McLeod RS, Onderdonk AB, Monohan-Earley RA, Cullen JB, Antonioli DA, et al. Ultrastructural evidence for piecemeal and anaphylactic degranulation of human gut mucosal mast cells in vivo. Int Arch Allergy Immunol 1992;99:74–83.
   PubMed Web of Science ®Google Scholar
• Balazs M, Illyes G, Vadasz G. Mast cells in ulcerative colitis. Quantitative and ultrastructural studies. Virchows Arch B Cell Pathol 1989;57:353–60.
   PubMedGoogle Scholar
• Rampton DS, Murdoch RD, Sladen GE. Rectal mucosal histamine release in ulcerative colitis. Clin Sci 1980;59:389–91.
   Google Scholar
• Knutson L, Ahrenstedt O, Odlind B, Hallgren R. The jejunal secretion of histamine is increased in active Crohn’s disease. Gastroenterology 1990;98:849–54.
   PubMedGoogle Scholar
• Marshall JS, Bienenstock J. Mast cells. Springer Semin Immunopathol 1990;12:191–202.
   PubMed Web of Science ®Google Scholar
• Crowe SE, Luthra GK, Perdue MH. Mast cell mediated ion transport in intestine from patients with and without inflammatory bowel disease. Gut 1997;41:785–92.
   PubMedGoogle Scholar
• Fox CC, Lazenby AJ, Moore WC, Yardley JH, Bayless TM, Lichtenstein LM. Enhancement of human intestinal mast cell mediator release in active ulcerative colitis. Gastroenterology 1990;99:119–24.
   PubMed Web of Science ®Google Scholar
• Heathly RV, Calcraft BJ, Rhodes J, Owen E, Evans BK. Disodium cromoglycate in the treatment of chronic proctitis. Gut 1975;16:559–63.
   PubMedGoogle Scholar
• Whorwell PJ, Whorwell GN, Bamforth J, Colin Jones D, Down P, Edwards A, et al. A double-blind controlled trial of the effect of sodium cromoglycate in preventing relapse in ulcerative colitis. Postgrad Med J 1981;57:436–8.
   PubMedGoogle Scholar
• Senju M. Reaginic hypersensitivity in ulcerative colitis. Jpn J Gastroenterol 1988;85:2168–77. In Japanese.
   Google Scholar
• Jewell DB, Truelove SC. Reaginic hypersensitivity in ulcerative colitis. Gut 1972;13:903–6.
   PubMed Web of Science ®Google Scholar
• Schwartz LB, Metcalve DD, Miller JS, Earl H, Sullivan T. Tryptase as an indicator of mast cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987;316:1622–6.
   PubMed Web of Science ®Google Scholar
• Cairns JA, Walls AF. Mast cell tryptase is a mitogen for epithelial cells. Stimulation of interleukin 8 production and intercellular adhesion molecule 1 expression. J Immunol 1996; 156:275–83.
   Google Scholar
• Alter CS, Schwartz LB. Tryptase: an indicator of mast cell mediated allergic reactions. In: Spector L, editor. Provocative challenge procedures: background and methodology. Mount Kisco, NY: Furuta; 1989. p. 167–83.
   Google Scholar
• Schwartz LB, Kawahara MS, Hugli TE, Vik D, Fearon DT, Austen KF. Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase. J Immunol 1983;130:1891–5.
   PubMed Web of Science ®Google Scholar
• Gruber BL, Schwartz LB. The mast cell as an effector of connective tissue degradation: a study of matrix susceptibility to human mast cells. Biochem Biophys Res Comm 1990;171: 1272–8.
   PubMed Web of Science ®Google Scholar
• Galli StJ, Maurer M, Lantz ChS. Mast cells as sentinels of innate immunity. Curr Opin Immunol 1999;11:53–9.
   PubMedGoogle Scholar
• Wershil BK, Furuta GT, Wang Z-S, Galli SJ. Mast cell- dependent neutrophil and mononuclear cell recruitment in immunoglobulin E-induced gastric reactions in mice. Gastroenterology 1996;110:1482–90.
   PubMedGoogle Scholar
• Montelone G, Biancone L, Marasco R, Morrone G, Marasco O, Luzza F, et al. Interleukin 12 is expressed and actively released by Crohn’s disease intestinal lamina propria mononuclear cells. Gastroenterology 1997;112:1169–78.
   PubMedGoogle Scholar